Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis: Improvement with Target Combination

Although the clinical application of new drugs has been shown to be effective in slowing disease progression and improving the quality of life in patients with pulmonary fibrosis, the damaged lung tissue does not recover with these drugs. Thus, there is an urgent need to establish regenerative thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Chuang, Hong-Meng, Shih, Tina Emily, Lu, Kang-Yun, Tsai, Sheng-Feng, Harn, Horng-Jyh, Ho, Li-Ing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299195/
https://www.ncbi.nlm.nih.gov/pubmed/29991279
http://dx.doi.org/10.1177/0963689718787501

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299195/
https://www.ncbi.nlm.nih.gov/pubmed/29991279
http://dx.doi.org/10.1177/0963689718787501

Ejemplares similares